Edition:
United States

People: Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

24.09USD
18 Jun 2018
Change (% chg)

$0.62 (+2.64%)
Prev Close
$23.47
Open
$23.46
Day's High
$24.47
Day's Low
$23.25
Volume
1,159,495
Avg. Vol
727,200
52-wk High
$26.45
52-wk Low
$7.20

Delaney, Brendan 

Mr. Brendan Delaney is Chief Commercial Officer of the Company. Mr. Brendan was most recently Vice President, U.S. Commercial Hematology Oncology at Celgene. In this role, Brendan oversaw a team of roughly 400 professionals across sales, marketing and strategic alliances. Notably, under Brendan's leadership, the revenue for the group grew to over $7 billion annually, representing a significant proportion of Celgene's global revenue. Prior to this role, Brendan held a series of other senior-level marketing roles at Celgene. Before coming to Celgene he was at Novartis for five years, serving in a number of U.S. and global marketing roles within the Company's oncology business unit. Over the course of his 22-year commercial career Brendan has been involved in the launch of nine new oncology products and indications.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --